Title	Publication Date	Language	Citations
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design	2014/06/01	English
Bevacizumab in the treatment of epithelial ovarian carcinoma	2014/06/01	English
News & Views	2014/06/01	English
The benefits of including expansion cohorts in Phase I oncology clinical trial design	2014/06/01	English
How can we manage resistance to antiangiogenic drugs?	2014/06/01	English
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis	2014/05/01	English
News	2014/05/01	English
Non-inferiority designs and novel antimicrobials	2014/05/01	English
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?	2014/05/01	English
Looking backwards to move forward: a review of randomized lung cancer treatment trials to inform future research	2014/05/01	English
Implementation of strategic management tools improves wound care clinical trial outcomes	2015/07/01	English
Linaclotide for irritable bowel syndrome with constipation: a review	2015/07/01	English
Nursing to regulator, rowing to digital health	2015/07/01	English
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal	2015/07/01	English
News	2012/05/01	English
Emerging clinical evidence in the treatment of eosinophilic esophagitis	2012/05/01	English
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials	2012/05/01	English
Evolving trial design in secondary progressive multiple sclerosis	2012/05/01	English
Over-reporting of p-values in the medical literature should be discouraged	2012/05/01	English
Denosumab in the treatment of bone metastases	2012/05/01	English
The evolving field of post-transplant therapy in multiple myeloma	2014/09/01	English
Managing safety in early phase trials: is there a gold standard?	2014/09/01	English
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate	2014/09/01	English
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations	2014/09/01	English
Anti-MET-targeted therapy for NSCLC: has it come of age?	2012/11/01	English
The trials of antiepileptic drug trials	2012/11/01	English
Targeted therapy for hepatocellular carcinoma: current status and future direction	2013/01/01	English
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design	2013/01/01	English
European Society for Medical Oncology 2012 annual meeting: update on oncology trials	2013/01/01	English
News	2013/01/01	English